ei-Nav/Artemis Helps Pinpoint Prostate Cancer, Provides a Map for Follow-up Care

GRASS VALLEY, Calif. -- A new imaging device, ei-Nav/Artemis(TM), now officially cleared by the U.S. Food and Drug Administration (FDA), offers urologists breakthrough technology that will significantly help in the fight against prostate cancer. Artemis, designed by Eigen, a Northern California-based company known for developing innovative, affordable medical imaging solutions, will be introduced at the American Urological Association's (AUA) annual meeting May 17 - 22 in Orlando, FL. Using proprietary next-generation 3D/4D imaging, Artemis(TM) provides solutions not available today by enhancing urologists' existing ultrasound machines, the vast majority of which are only 2D. Now, Artemis allows urologists to virtually...